A therapy using a patient's own proximal basal stem cells shows promise to treat idiopathic pulmonary fibrosis.

Columnist Ann Reynoso says she's struggling to lose weight, but each step forward, no matter how small, is still progress.

Pliant Therapeutics has discontinued a pivotal Phase 2b/3 clinical trial evaluating bexotegrast as an IPF treatment.

Living with pulmonary fibrosis (PF) is not for the faint of heart. That applies equally to patients, caregivers, and loved ones. While each of us is on a unique journey, there are times when support ...

It was five years ago this month that COVID-19 was beginning to consume the headlines. Around the world, those headlines provided an early view of what a pandemic might look like here in the U.S. In ...

Enrollment is now complete in a Phase 2b clinical trial, dubbed CORAL, that’s testing nalbuphine extended-release (ER) tablets — planned to be marketed as Haduvio — in people with idiopathic pulmonary ...

Do you ever have one of those days? You know the kind: Nothing seems to go your way and the day ends with a huge sigh. When I was diagnosed with idiopathic pulmonary fibrosis, I learned that not every ...

Fraternal organizations have long been a part of colleges and universities. It’s not uncommon to find an area around campus labeled as Greek Row. These organizations allow like-minded individuals to ...